PCM
Puissance Capital Management Portfolio holdings
AUM
$17.3M
This Quarter Return
-39.47%
1 Year Return
+149.36%
3 Year Return
+115.5%
5 Year Return
–
10 Year Return
–
AUM
$87.7M
AUM Growth
+$87.7M
(-39%)
Cap. Flow
+$3.17M
Cap. Flow
% of AUM
3.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$1.41M |
| 2 |
Corvus Pharmaceuticals
CRVS
|
$1.05M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$716K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 44.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
| $41.5M | 47.38% | 6,842,975 | – | – |
|
2
Ekso Bionics
EKSO
$9.79M
| $25.5M | 29.04% | 20,534,898 | – | – |
|
|
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
| $9.36M | 10.68% | 4,499,352 +677,302 | +18% | +$1.41M |
|
|
BLPH
4
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $6.65M | 7.59% | 8,298,755 | – | – |
|
|
TCON
5
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $2.9M | 3.31% | 4,601,768 | – | – |
|
|
6
Corvus Pharmaceuticals
CRVS
$428M
| $1.05M | 1.19% | +284,869 | New | +$1.05M |
|
|
7
SPDR S&P Biotech ETF
XBI
$5.07B
| $716K | 0.82% | +9,986 | New | +$716K |
|